Loading news...
PetVivo Holdings, Inc. (NASDAQ: PETV - Get Free Report)'s share price dropped 11% during trading on Tuesday. The stock traded as low as $0.6873 and last traded at $0.7050. Approximately 16,865 shares were traded during trading, an increase of 19% from the average daily volume of 14,208 shares. The stock had previously closed at $0.7920.
PetVivo Holdings, Inc. (PETV) Q3 2026 Earnings Call Transcript
MINNEAPOLIS, MN, US, Feb. 17, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTC ID: PETVW), and its wholly owned subsidiaries PetVivo Animal Health and PetVivo AI, a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, reported financial and operational results for the third quarter and first nine months of its fiscal year 2026 ended December 31, 2025.
MINNEAPOLIS, MN, US, Feb. 10, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., in collaboration with its wholly-owned subsidiary PetVivo Animal Health (OTCQX: PETV; OTCID: PETVW), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, today announced that it is retracting and replacing its previously issued press release dated February 9, 2026 regarding the Company's fiscal third quarter 2026 conference call.
MINNEAPOLIS, MN, US, Feb. 09, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., including its wholly-owned subsidiary Petvivo Animal Health, Inc. (OTCQX: PETV; OTCID: PETVW), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Monday, February 16, 2026 at 5:00 p.m. Eastern time to discuss results for the fiscal third quarter ended December 31, 2025. The financial results will be issued in a press release prior to the call.
MINNEAPOLIS, MN / ACCESS Newswire / December 23, 2025 / PetVivo Holdings, Inc. (OTCQX:PETV)(OTCID:PETVW), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026. John Lai, Chief Executive Officer of PetVivo Holdings, Inc., will deliver a company presentation and be available for one-on-one investor meetings throughout the event.
Revolutionary Veterinary AI Platform Ditches Dense Documentation in Favor of Clear, Engaging Video Walkthrough MINNEAPOLIS, MN, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PetVivo.ai, the AI powered platform transforming how veterinary practices connect with pet parents, today announced something different: instead of another lengthy press release filled with jargon, they made a video. "Let's be honest," said John Lai, CEO at PetVivo Holdings (OTCQX: PETV; OTCID: PETVW).
Revolutionary PetVivo.ai Uses Nine AI Agents to Transform $150B Pet Care Market Important Disclaimer: This updated press release replaces and supersedes the version issued earlier this morning, which should be disregarded due to inaccurate or incomplete information. MINNEAPOLIS, Nov. 25, 2025 (GLOBE NEWSWIRE) -- PetVivo AI, Inc., in cooperation with its parent PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) and affiliate PetVivo Animal Health, Inc., an emerging biomedical device company focused on commercializing groundbreaking medical products and therapeutics for horses and companion animals, today announced the launch of PetVivo.ai.
PetVivo Holdings, Inc. (OTCPK:PETV) Q2 2026 Earnings Call November 14, 2025 5:00 PM EST Company Participants John Dolan - General Counsel, Chief Business Development Officer & Secretary Garry Lowenthal - Chief Financial Officer Michael Eldred - Commercialization & Operations Advisor and Executive Director John Lai - CEO, President & Director Presentation John Dolan General Counsel, Chief Business Development Officer & Secretary Good afternoon, everyone. Thank you for joining us today to discuss our results for our second quarter of fiscal 2026, which ended on September 30, 2025.
MINNEAPOLIS, MN, US, Nov. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTC ID: PETVW), through its wholly owned subsidiary Petvivo Animal Health, a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, reported results for its second quarter and first half of fiscal year 2026 ended September 30, 2025.
MINNEAPOLIS, MN, US, Nov. 07, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) and its wholly-owned subsidiary Petvivo Animal Health, Inc., a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Friday, November 14, 2025 at 5:00 p.m. Eastern time to discuss results for the fiscal second quarter ended September 30, 2025. The financial results will be issued in a press release prior to the call.
MINNEAPOLIS, MN, US, Oct. 28, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID PETVW), in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., both emerging biomedical device companies focused on the commercialization of innovative medical therapeutics for companion animals and animal athletes is pleased to announce that Josh Ruben has joined the Company's Board of Directors.
On-demand programs deliver clinically relevant science, technical instruction, and case applications in small animal and equine practice
MINNEAPOLIS, Sept. 11, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), working in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., (collectively "PetVivo" or the “Company”), an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for horses and companion animals, announced today that John Lai, Chief Executive Officer of PetVivo, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on September 18th, 2025.
PetVivo Holdings, Inc. (OTCPK:PETV) Q1 2026 Earnings Conference Call August 14, 2025 5:00 PM ET Company Participants Garry N. Lowenthal - Chief Financial Officer John Lai - CEO, President & Director John F.
MINNEAPOLIS, MN, US, Aug. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., including its wholly-owned subsidiary Petvivo Animal Health, Inc. (OTCQX: PETV; OTC ID: PETVW), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, reported results for its first quarter of fiscal year 2026 ended June 30, 2025. All comparisons are to the previous year first quarter period ending June 30, 2024, unless otherwise noted.
MINNEAPOLIS, MN, US, Aug. 07, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Thursday, August 14, 2025 at 5:00 p.m. Eastern time to discuss results for the fiscal first quarter ended June 30, 2025. The financial results will be issued in a press release prior to the call.
MINNEAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX PETV; OTCID: PETVW) working in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”), an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for horses and companion animals, such as Spryng® with OsteoCushion® Technology and PrecisePRP®, today announced that the Company has qualified to trade on the OTCQX® Best Market. PetVivo Holdings Inc. upgraded to OTCQX from the OTCQB® Venture Market.
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced PetVivo Holdings Inc. (OTCQX: PETV), an emerging biomedical device company, has qualified to trade on the OTCQX® Best Market. PetVivo Holdings Inc. upgraded to OTCQX from the OTCQB® Venture Market.
PetVivo Holdings, Inc. (OTCPK:PETV) Q4 2025 Earnings Conference Call June 30, 2025 5:00 PM ET Company Participants Garry N. Lowenthal - Chief Financial Officer John Lai - CEO, President & Director John F.